As reported post implant of the ventralex mesh, the patient developed surgical site infection, underwent percutaneous aspiration of infectious seroma and prescribed with oral antibiotics.The clinician has assessed the patient¿s postoperative course as being ¿possibly¿ related to the study device and possibly related to the procedure, however, based on the information provided, no conclusion can be made.Post operative infection and seroma formation are known inherent risks of surgery.The instructions-for-use (ifu) supplied with the device lists infection and seroma as possible complications.In regards to infection, the warning section of the ifu states, "if an infection develops, treat the infection aggressively.Consideration should be given regarding the need to remove the patch.An unresolved infection may require removal of the device." a lot number was not provided, without a lot number a review of the manufacturing records could not be conducted.Not returned - remains implanted.
|
Reported per clinical trial (b)(4): on (b)(6) 2011 - subject patient underwent open midline umbilical repair and lysis of adhesions during which a bard/davol ventralex hernia patch was implanted with mechanical sutures.Fascia and full skin closure was achieved using non-bard/davol prolene and surgical glue.The patient was discharged to home on (b)(6) 2011.On (b)(6) 2011 - subject patient was diagnosed with surgical site infection, was treated with oral antibiotics and percutaneous aspiration of infectious seroma at the surgical site in the clinic.Per the study clinician, the reported adverse event has been assessed as mild in severity, possibly related to the study device and possibly related to the index procedure.The outcome for this ae is reported as recovered/resolved.
|